Launch Isomorphic Labs: Revolutionizing Drug Development with AI
Demis Hassabis, co-founder and CEO of Google's DeepMind, announced the launch of Isomorphic Labs. The company aims to leverage artificial intelligence technologies to accelerate the development of new drugs, marking a significant step in the biotechnology field.